|
|
|
|
|
|
Intersect Ent (XENT)
|
|
29.75 +0.50 (+1.71%)
|
9/22/2017 4:00pm
|
|
Open:
|
29.30
|
Pre. Close:
|
29.25
|
|
High:
|
30.00
|
Low:
|
29.30
|
|
Volume:
|
161,527
|
Market Cap:
|
868.37M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
30.54 - 30.9
|
30.9 - 31.16
|
|
Low:
|
28.31 - 28.75
|
28.75 - 29.05
|
|
Close:
|
29.1 - 29.86
|
29.86 - 30.39
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-22 4:46:03 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 36.81 One year: 38.84
|
|
Support:
|
Support1: 28.70 Support2: 23.88
|
|
Resistance:
|
Resistance1:
31.51 Resistance2: 33.25
|
|
Pivot:
|
30.86 
|
|
Moving Averages:
|
MA(5): 29.85 MA(20): 30.66
MA(100): 27.80 MA(250): 19.57
|
|
MACD:
|
MACD(12,26):
-0.07 Signal(12,26,9): 0.22
|
|
%K %D:
|
%K(14,3): 14.75 %D(3): 18.42
|
|
RSI:
|
RSI(14): 45.11
|
|
52-Week:
|
High: 33.25
Low: 7.65 Change(%): 85.6
|
|
Average Vol(K):
|
3-Month: 26902
10-Days 9033
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.XENT has closed above bottom band by 22.7%. Bollinger Bands are 1.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Mon, 22 May 2017 11:00:52 GMT
Intersect ENT Announces PDUFA Date for Office-Based SINUVA™ Steroid Releasing ...
Fri, 24 Feb 2017 13:00:53 GMT
Intersect ENT Announces FDA Approval of Newest Steroid Releasing Implant, PROPEL
Wed, 03 May 2017 18:44:36 GMT
Why Intersect ENT Shares Are Rallying 17% Today
Wed, 02 Nov 2016 16:52:30 GMT
Why Intersect ENT Shares Are Crashing 43% Today
Fri, 07 Jul 2017 16:41:15 GMT
Commit To Buy Intersect ENT At $22.50, Earn 15.7% Annualized Using Options
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
